50
Participants
Start Date
November 1, 2018
Primary Completion Date
September 20, 2019
Study Completion Date
March 1, 2020
Prolotherapy
It consists of injecting 5% dextrose in sterile aqueous solution without the use of lidocaine in a subcutaneous nerve to inhibit neurogenic inflammation and the release of substance P and CGRP, decreasing neurogenic inflammation.
Centro Médico Nacional de Occidente, Guadalajara
Instituto Mexicano del Seguro Social
OTHER_GOV